German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.

German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.

The prospective multicenter NOA-03 trial, conducted by the Neuro-Oncology Working Group (NOA) of the German Cancer Society, was initiated to define the feasibility and efficacy of single-agent high-dose methotrexate therapy without concomitant radiotherapy in immunocompetent patients with primary ce...

Full description

Bibliographic Details
Main Authors: Herrlinger, U, Schabet, M, Brugger, W, Kortmann, R, Küker, W, Deckert, M, Engel, C, Schmeck-Lindenau, H, Mergenthaler, H, Krauseneck, P, Benöhr, C, Meisner, C, Wiestler, O, Dichgans, J, Kanz, L, Bamberg, M, Weller, M
Format: Journal article
Language:English
Published: 2002

Similar Items